Healthcare has entered a new era of technology. Artificial intelligence (AI), regenerative medicine, and digital health have opened up new opportunities for diagnosis, treatment, and rehabilitation.

April01,2026 Related Topics: Up Next Healthcare CEO Outlook 2025, KPMG Don't Miss Transformative technologies for the healthcare system, Politecnico di Milano ...

India’s diagnostic landscape is expanding rapidly, yet the growth remains uneven. The divide between urban and rural India continues to define healthcare outcomes for millions. While metros and Tier-I ...

Craif Inc announced the close of its approximately $33 million Series D, bringing total capital raised since the company’s founding to roughly $88 million. Craif will use the proceeds to strengthen ...

India imports between 70% and 80% of its medical devices by value. For a country that styles itself the pharmacy of the world, that figure is not merely an economic inconvenience, it is a structural ...

Anderson Diagnostics and Labs, backed by Tata Capital Healthcare Fund, has initiated a process to raise about ₹250 crore through a mix of primary and secondary transactions, according to two people ...

India is rapidly shifting from being viewed simply as an affordable destination for treatment to becoming a genuine global medical tourism hub, with foreign patient volumes and market size both ...

Private equity giant Advent International has approached the fair trade regulator CCI, seeking approval to acquire a 24.9 per cent stake in multi-speciality healthcare provider Yatharth Hospitals.

A Bajaj Broking Prive report puts a number on something that’s been building for years: India’s large private hospital networks are planning roughly Rs 40,000 crore of fresh CapEx to add more than ...

India’s first humanized CAR-T cell therapy, called NexCAR19, marks a historic milestone in the country’s biotechnology landscape. This groundbreaking therapy was developed by ImmunoACT, an Indian ...

Are you frequently caught in lengthy lines for your ultrasound, MRI, or CT scans? The waiting time for receiving the comprehensive reports can be quite extensive as well. You can lay the blame at the ...

Central Drugs Standard Control Organisation (CDSCO) has released a risk classification list of medical devices pertaining to oncology. “Consequent to the publication of the draft list vide File No.